All ProductsDisplaying Products by Catalog Number (7000 - 7099)
01000200030004000500060007000800090010001100120013001400150016001700180019002000210022002300240025002600270028002900300031003200330034003500360037003800390040004100420043004400450046004700480049005000510052005300540055005600570058005900600061006200630064006500660067006800690070007100720073007400750076007700780079008000
| Cat. No. | Product Name / Activity |
|---|---|
| 7001 | AT 7867 |
| Potent pan-Akt and PKA inhibitor | |
| 7002 | KYA 1797K |
| Wnt/β-catenin signaling inhibitor | |
| 7004 | NAI |
| Reagent for RNA SHAPE-MaP experiments in vivo; cell permeable | |
| 7005 | 4-Thiouridine |
| Photoreactive uridine analog for RNA sequencing | |
| 7006 | PDD 00017272 |
| Potent PARG inhibitor | |
| 7007 | PDD 00017238 |
| High affinity and potent PARG inhibitor | |
| 7009 | PDD 00031705 |
| Negative control for PDD 00017238 (Cat. No. 7007) | |
| 7010 | EM 163 |
| TIR-TIR interaction inhibitor | |
| 7013 | OptoBI-1 |
| Photoswitchable TRPC3/6/7 agonist | |
| 7015 | IA-Alkyne |
| Broad spectrum cysteine reactive probe | |
| 7018 | CBR-470-1 |
| PGK1 inhibitor; activates Nrf2 | |
| 7020 | LDV |
| α4β1 (VLA-4) ligand | |
| 7026 | Veliparib dihydrochloride |
| High affinity PARP-1 and -2 inhibitor; orally bioavailable | |
| 7027 | LY 2033298 |
| Selective positive allosteric modulator of M4 receptors; active in vivo; antipsychotic | |
| 7029 | GX 201 |
| Potent and selective Nav1.7 blocker; analgesic | |
| 7030 | GW 280264X |
| Potent ADAM10 and ADAM17 inhibitor | |
| 7033 | AY 77 |
| Potent PAR2 biased agonist; exhibits bias for Ca2+ signaling | |
| 7034 | AY 254 |
| Potent PAR2 biased agonist; exhibits bias for ERK1/2 signaling | |
| 7038 | Palonosetron hydrochloride |
| Highly potent and high affinity 5-HT3 antagonist | |
| 7039 | SK 609 |
| Dopamine D3 receptor biased agonist | |
| 7040 | C 176 |
| mSTING antagonist | |
| 7044 | (±)-α-Lipoic acid |
| Liquid-liquid phase separated condensate modifier; reduces stress granule formation | |
| 7045 | (±)-α-Lipoamide |
| Phase-separated condensate modifier; orally bioavailable | |
| 7046 | 1,6-Hexanediol |
| Tool for probing liquid-liquid phase separation | |
| 7048 | Ruxolitinib phosphate |
| Phosphate salt of Ruxolitinib (Cat. No. 7064); potent and selective JAK1/JAK2 inhibitor | |
| 7049 | Nintedanib |
| Potent VEGFR, PDGFR and FGFR inhibitor | |
| 7050 | Ribociclib |
| Dual cdk4/cdk6 inhibitor; orally bioavailable | |
| 7051 | Tasquinimod |
| High affinity HDAC4 negative allosteric modulator; also binds S100A9; antiangiogenic | |
| 7052 | Lopinavir |
| Highly potent and selective HIV-1 protease inhibitor | |
| 7054 | T4 |
| Modulator of alternative polyadenylation; inhibits rod photoreceptor gene expression via Nr2e3 | |
| 7055 | WS 383 |
| Potent, selective and reversible DCN1-UBC12 interaction inhibitor | |
| 7056 | Conduritol B epoxide |
| Irreversible glucocerebrosidase (β-glucosidase) inhibitor; used to generate Gaucher disease models | |
| 7057 | VU 0071063 |
| Selective activator of SUR1 Kir6.2 channels | |
| 7059 | GLPG 0187 |
| Potent αv integrin inhibitor | |
| 7064 | Ruxolitinib |
| Potent and selective JAK1/JAK2 inhibitor; orally bioavailable | |
| 7065 | Kainic acid (synthetic) |
| Kainate agonist; excitant and neurotoxin | |
| 7066 | RCGD 423 |
| gp130 modulator; activates JAK/STAT signaling | |
| 7070 | Mirabegron |
| Potent and selective β3 agonist | |
| 7071 | GSK 2239633A |
| Potent CCR4 antagonist | |
| 7073 | VH 032 amide-alkylC3-amine |
| VHL ligand with alkyl linker and terminal amine for onward chemistry | |
| 7074 | VH 032 amide-alkylC7-amine |
| VHL ligand with alkyl linker and terminal amine for onward chemistry | |
| 7075 | Lenalidomide 4'-PEG1-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 7076 | Lenalidomide 4'-PEG3-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 7081 | LY 2886721 Hydrochloride |
| Potent and selective β-secretase (BACE) inhibitor | |
| 7082 | DL 175 |
| Potent and selective GPR84 agonist | |
| 7086 | StemRegenin 1 |
| Aryl hydrocarbon receptor (AhR) antagonist; promotes HSC expansion and engraftment | |
| 7087 | AGI 5198 |
| Potent and selective inhibitor of mutant isocitrate dehydrogenase 1 (mIDH1) | |
| 7088 | Janelia Fluor® 646, Azide |
| Red dye (Reactive group: azide). Applications: super resolution microscopy e.g. dSTORM & STED, confocal, and live cell imaging | |
| 7089 | CSN5i-3 |
| Potent and selective CSN5 (COP9 signalosome) inhibitor | |
| 7091 | Miro1 Reducer |
| Promotes mitochondrial Rho GTPase 1 (Miro1) degradation | |
| 7093 | Lenalidomide 4'-PEG2-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 7094 | Pomalidomide 4'-PEG1-acid |
| Cereblon ligand with PEG linker and terminal acid for onward chemistry | |
| 7095 | Pomalidomide 4'-PEG5-acid |
| Cereblon ligand with PEG linker and terminal acid for onward chemistry | |
| 7096 | Pomalidomide 4'-alkylC3-acid |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
| 7097 | Pomalidomide 4'-alkylC7-acid |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry |